MARATTO

review · BMC Women s Health

Efficacy and safety of 12-hour versus 24-hour magnesium sulfate in management of patients with pre-eclampsia and eclampsia: a systematic review and meta-analysis

202410 citationsOpen accessBenha University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

Our study showed no statistically significant difference in effectiveness and toxicity risk between the 12-h and 24-h regimens.

Research topics

  • Pregnancy and preeclampsia studies
  • Maternal and fetal healthcare
  • Pregnancy and Medication Impact

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher siteRecord on OpenAlex

DOI: 10.1186/s12905-024-03271-0

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

Sign in to join the discussion

New to MARATTO™? Create a free account.